Foghorn Therapeutics Inc. Contracts & Agreements

Letter Agreement between Foghorn Therapeutics Inc. and Anna Rivkin, dated July 18, 2024 (Filed With SEC on November 4, 2024)

Form of Pre-Funded Warrant (Filed With SEC on May 22, 2024)

Underwriting Agreement dated May 20, 2024, by and among Foghorn Therapeutics Inc. and Jefferies LLC, TD Securities (USA) LLC and Evercore Group L.L.C, as representatives of the... (Filed With SEC on May 22, 2024)

[Remainder of Page Intentionally Left Blank] (Filed With SEC on April 16, 2024)

Consulting Agreement between Foghorn Therapeutics Inc. and Ian F. Smith, dated as of December 8, 2023 (Filed With SEC on March 7, 2024)

Letter Agreement between Foghorn Therapeutics Inc. and Alfonso Quints Cardama, M.D., dated August 4, 2023 (Filed With SEC on November 2, 2023)

Form of Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement for use between Foghorn Therapeutics Inc. and its executive officers, updated July 2022 (Filed With SEC on August 9, 2022)

Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Carlos Costa, dated July 15, 2022 (Filed With SEC on August 9, 2022)

First Amendment to Lease by and between ARE-Tech Square, LLC and Foghorn Therapeutics Inc. dated June 29, 2020 (Filed With SEC on May 9, 2022)

Sales Agreement, dated as of April 15, 2022, by and between Foghorn Therapeutics Inc. and Cowen and Company, LLC (Filed With SEC on April 15, 2022)

Stock Purchase Agreement, dated as of December 10, 2021, between Foghorn Therapeutics Inc. and Eli Lilly and Company (Filed With SEC on December 13, 2021)

Amendment to Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 10, 2021 (Filed With SEC on December 13, 2021)

Consulting Agreement by and Between Ian F. Smith and Foghorn Therapeutics Inc., dated as of June 23, 2021 (Filed With SEC on August 10, 2021)

First Amendment to Loan and Security Agreement dated as of June 14, 2021, among Oxford Finance LLC and Foghorn Therapeutics Inc (Filed With SEC on June 15, 2021)

Amendment to Consulting Agreement between Foghorn Therapeutics Inc. and Cigall Kadoch dated October 29, 2020 (Filed With SEC on March 18, 2021)

Description of Registrants Securities (Filed With SEC on March 18, 2021)

Loan and Security Agreement dated as of November 19, 2020, among Oxford Finance LLC, and Foghorn Therapeutics Inc (Filed With SEC on November 25, 2020)

Form of Warrant to Purchase Common Stock of Foghorn Therapeutics Inc., dated as of November 19, 2020 (Filed With SEC on November 25, 2020)

Form of Non-Statutory Stock Option Agreement (Employees) under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan (Filed With SEC on October 19, 2020)

Consulting Agreement between Foghorn Therapeutics Inc. and Cigall Kadoch, dated October 1, 2015 (Filed With SEC on October 19, 2020)

Foghorn Therapeutics Inc. 2020 Cash Incentive Plan (Filed With SEC on October 19, 2020)

Foghorn Therapeutics Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on October 19, 2020)

Form of Non-Statutory Stock Option Agreement (Non-Employee Directors) under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan (Filed With SEC on October 19, 2020)

Form of Incentive Stock Option Agreement under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan (Filed With SEC on October 19, 2020)

Foghorn Therapeutics Inc. 2020 Equity Incentive Plan (Filed With SEC on October 19, 2020)

Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Carl P. Decicco, Ph.D., dated October 14 (Filed With SEC on October 19, 2020)

Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Samuel Agresta, M.D., M.P.H. & T.M., dated October 14 (Filed With SEC on October 19, 2020)

Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Adrian Gottschalk, dated October 14, 2020 (Filed With SEC on October 19, 2020)

Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 18, 2018 (Filed With SEC on October 19, 2020)

Specimen stock certificate evidencing shares of common stock (Filed With SEC on October 19, 2020)

Form of Underwriting Agreement (Filed With SEC on October 19, 2020)

Amendment to the Investors Rights Agreement and the Voting Agreement, dated December 18, 2018, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of... (Filed With SEC on October 2, 2020)

Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 18, 2018 (Filed With SEC on October 2, 2020)

Form of Warrant to Purchase Series A-2 Preferred Stock of the Registrant issued to Silicon Valley Bank, dated November 29, 2016 (Filed With SEC on October 2, 2020)

Lease Agreement by and between ARE-MA Region No. 45, LLC and Foghorn Therapeutics Inc., dated August 24, 2017 (Filed With SEC on October 2, 2020)

Lease Agreement by and between ARE-Tech Square, LLC and Foghorn Therapeutics Inc., dated October 23, 2019 (Filed With SEC on October 2, 2020)

Exclusive Collaboration and License Agreement, by and between Merck Sharp & Dohme Corp. and Foghorn Therapeutics Inc., dated as of July 2, 2020 (Filed With SEC on October 2, 2020)

Foghorn Therapeutics Inc. 2016 Stock Incentive Plan, as amended (Filed With SEC on October 2, 2020)

Form of Stock Restriction Agreement under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan (Filed With SEC on October 2, 2020)

Form of Incentive Stock Option Grant Notice under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan (Filed With SEC on October 2, 2020)

Form of Non-Qualified Stock Option Grant Notice under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan (Filed With SEC on October 2, 2020)

Form of Indemnification Agreement between Foghorn Therapeutics Inc. and its directors and officers (Filed With SEC on October 2, 2020)

Letter Agreement between Foghorn Therapeutics Inc. and Adrian Gottschalk, dated April 20, 2017 (Filed With SEC on October 2, 2020)

Letter Agreement between Foghorn Therapeutics Inc. and Samuel Agresta, M.D., M.P.H. & T.M., dated July 11, 2019 (Filed With SEC on October 2, 2020)

Letter Agreement between Foghorn Therapeutics Inc. and Carl P. Decicco, Ph.D., dated December 5, 2018 (Filed With SEC on October 2, 2020)

Category

Industry

Companies

Contracts

Foghorn Therapeutics Inc. Contracts & Agreements